Application
Fig1: Western blot analysis of CD29 on different cell lysates using anti-CD29 antibody at 1/1000 dilution. Positive control:
Lane 1: Human liver
Lane 2: Human kidney
Lane 3: NIH/3T3
Lane 4: A172
Lane 5: Hela
Application
Fig2: Immunohistochemical analysis of paraffin-embedded human liver carcinoma tissue using anti-CD29 antibody. Counter stained with hematoxylin.
Application
Fig3: Immunohistochemical analysis of paraffin-embedded human colon carcinoma tissue using anti-CD29 antibody. Counter stained with hematoxylin.
Application
Fig4: Flow cytometric analysis of HepG2 cells with CD29 antibody at 1/100 dilution (blue) compared with an unlabelled control (cells without incubation with primary antibody; red). Goat anti rabbit IgG (FITC) was used as the secondary antibody.